These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
573 related items for PubMed ID: 15623264
21. Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs. Mosis G, Stijnen T, Castellsague J, Dieleman JP, van der Lei J, Stricker BH, Sturkenboom MC. Arthritis Rheum; 2006 Aug 15; 55(4):537-42. PubMed ID: 16874797 [Abstract] [Full Text] [Related]
22. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Ray WA, Chung CP, Stein CM, Smalley WE, Hall K, Arbogast PG, Griffin MR. Gastroenterology; 2007 Sep 15; 133(3):790-8. PubMed ID: 17854591 [Abstract] [Full Text] [Related]
23. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population. Rahme E, Pettitt D, LeLorier J. Arthritis Rheum; 2002 Nov 15; 46(11):3046-54. PubMed ID: 12428249 [Abstract] [Full Text] [Related]
24. Upper gastrointestinal symptoms and therapies in elderly out-patients, users of non-selective NSAIDs or coxibs. Pilotto A, Franceschi M, Vitale DF, Zaninelli A, Masotti G, Rengo F, F.I.R.I. (Fondazione Italiana Ricerca Sull'Invecchiamento), Sofia Project Investigators. Aliment Pharmacol Ther; 2005 Jul 15; 22(2):147-55. PubMed ID: 16011673 [Abstract] [Full Text] [Related]
27. A very high rate of inappropriate use of gastroprotection for nonsteroidal anti-inflammatory drug therapy in primary care: a cross-sectional study. Morini S, Zullo A, Oliveti D, Chiriatti A, Marmo R, Chiuri DA, Marotti G, Morelli L, Hassan C. J Clin Gastroenterol; 2011 Oct 15; 45(9):780-4. PubMed ID: 21918387 [Abstract] [Full Text] [Related]
28. Impact of selective cyclooxygenase-2 inhibitors on anti-ulcer medication and non-steroidal anti-inflammatory drug use in patients with rheumatic disease. Joshua FF, Oakley SP, Major GA. Intern Med J; 2004 Apr 15; 34(4):153-61. PubMed ID: 15086694 [Abstract] [Full Text] [Related]
30. Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Battistella M, Mamdami MM, Juurlink DN, Rabeneck L, Laupacis A. Arch Intern Med; 2005 Jan 24; 165(2):189-92. PubMed ID: 15668365 [Abstract] [Full Text] [Related]
32. Over and under-utilization of cyclooxygenase-2 selective inhibitors by primary care physicians and specialists: the tortoise and the hare revisited. De Smet BD, Fendrick AM, Stevenson JG, Bernstein SJ. J Gen Intern Med; 2006 Jul 24; 21(7):694-7. PubMed ID: 16808768 [Abstract] [Full Text] [Related]
33. Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologists. Greenberg JD, Bingham CO, Abramson SB, Reed G, Sebaldt RJ, Kremer J. Arthritis Rheum; 2005 Feb 15; 53(1):12-7. PubMed ID: 15696570 [Abstract] [Full Text] [Related]
34. Physician characteristics and prescribing for elderly people in New Brunswick: relation to patient outcomes. Davidson W, Molloy DW, Bédard M. CMAJ; 1995 Apr 15; 152(8):1227-34. PubMed ID: 7736373 [Abstract] [Full Text] [Related]
39. A cross-sectional retrospective assessment of anti-arthritic drugs in patients with arthritis in Korea. Lee MC, Lee S, Suh DC, Kim J, Kong SX, Korea Arthritis Study Group. Curr Med Res Opin; 2003 Sep 15; 19(7):597-602. PubMed ID: 14606981 [Abstract] [Full Text] [Related]